ArticleCancer research2022

Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL.

Russell Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.